• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H3K27M 诱导 PRC2 介导的抑制性 H3K27me2/me3 染色质扩散缺陷,并对神经胶质瘤发生至关重要。

H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis.

机构信息

Department of Human Genetics, McGill University, Montreal, QC, H3A 1B1, Canada.

Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.

出版信息

Nat Commun. 2019 Mar 19;10(1):1262. doi: 10.1038/s41467-019-09140-x.

DOI:10.1038/s41467-019-09140-x
PMID:30890717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6425035/
Abstract

Lys-27-Met mutations in histone 3 genes (H3K27M) characterize a subgroup of deadly gliomas and decrease genome-wide H3K27 trimethylation. Here we use primary H3K27M tumor lines and isogenic CRISPR-edited controls to assess H3K27M effects in vitro and in vivo. We find that whereas H3K27me3 and H3K27me2 are normally deposited by PRC2 across broad regions, their deposition is severely reduced in H3.3K27M cells. H3K27me3 is unable to spread from large unmethylated CpG islands, while H3K27me2 can be deposited outside these PRC2 high-affinity sites but to levels corresponding to H3K27me3 deposition in wild-type cells. Our findings indicate that PRC2 recruitment and propagation on chromatin are seemingly unaffected by K27M, which mostly impairs spread of the repressive marks it catalyzes, especially H3K27me3. Genome-wide loss of H3K27me3 and me2 deposition has limited transcriptomic consequences, preferentially affecting lowly-expressed genes regulating neurogenesis. Removal of H3K27M restores H3K27me2/me3 spread, impairs cell proliferation, and completely abolishes their capacity to form tumors in mice.

摘要

组蛋白 3 基因(H3K27M)中的 Lys-27-Met 突变特征是致命性神经胶质瘤的一个亚组,并降低全基因组 H3K27 三甲基化。在这里,我们使用原代 H3K27M 肿瘤系和同源 CRISPR 编辑对照来评估 H3K27M 在体外和体内的影响。我们发现,虽然 PRC2 通常在广泛的区域内沉积 H3K27me3 和 H3K27me2,但在 H3.3K27M 细胞中其沉积严重减少。H3K27me3 无法从大的未甲基化 CpG 岛传播,而 H3K27me2 可以在这些 PRC2 高亲和力位点之外沉积,但水平对应于野生型细胞中 H3K27me3 的沉积。我们的研究结果表明,PRC2 在染色质上的募集和传播似乎不受 K27M 的影响,K27M 主要损害其催化的抑制性标记的传播,尤其是 H3K27me3。全基因组丧失 H3K27me3 和 me2 沉积对转录组的影响有限,优先影响调节神经发生的低表达基因。去除 H3K27M 可恢复 H3K27me2/me3 的传播,损害细胞增殖,并完全消除其在小鼠中形成肿瘤的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/288a0af05457/41467_2019_9140_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/6bc5b122644f/41467_2019_9140_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/bf4620f81fa6/41467_2019_9140_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/724f15b3a39e/41467_2019_9140_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/8e2c47b56f84/41467_2019_9140_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/288a0af05457/41467_2019_9140_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/6bc5b122644f/41467_2019_9140_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/bf4620f81fa6/41467_2019_9140_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/724f15b3a39e/41467_2019_9140_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/8e2c47b56f84/41467_2019_9140_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5273/6425035/288a0af05457/41467_2019_9140_Fig5_HTML.jpg

相似文献

1
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis.H3K27M 诱导 PRC2 介导的抑制性 H3K27me2/me3 染色质扩散缺陷,并对神经胶质瘤发生至关重要。
Nat Commun. 2019 Mar 19;10(1):1262. doi: 10.1038/s41467-019-09140-x.
2
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.弥漫性脑桥内在型胶质瘤中多梳蛋白和BET溴结构域蛋白的治疗靶点
Nat Med. 2017 Apr;23(4):493-500. doi: 10.1038/nm.4296. Epub 2017 Feb 27.
3
H3F3A K27M mutations drive a repressive transcriptome by modulating chromatin accessibility independent of H3K27me3 in Diffuse Midline Glioma.在弥漫性中线胶质瘤中,H3F3A K27M突变通过独立于H3K27me3调节染色质可及性来驱动抑制性转录组。
Epigenetics Chromatin. 2025 Apr 26;18(1):23. doi: 10.1186/s13072-025-00585-7.
4
H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation.H3K27M 在神经胶质瘤中导致 H3K27 甲基化的一步降低,并在 H3K36 甲基化的限制内减少扩散。
Cell Rep. 2020 Nov 17;33(7):108390. doi: 10.1016/j.celrep.2020.108390.
5
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.EZH2 是 H3K27M 突变型小儿脑胶质瘤的潜在治疗靶点。
Nat Med. 2017 Apr;23(4):483-492. doi: 10.1038/nm.4293. Epub 2017 Feb 27.
6
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.功能获得性 H3 突变抑制 PRC2 活性,该突变存在于小儿脑胶质瘤中。
Science. 2013 May 17;340(6134):857-61. doi: 10.1126/science.1232245. Epub 2013 Mar 28.
7
Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.染色质调节因子 PRC2 是胶质母细胞瘤中表观遗传可塑性的关键调节因子。
Cancer Res. 2013 Jul 15;73(14):4559-70. doi: 10.1158/0008-5472.CAN-13-0109. Epub 2013 May 29.
8
Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2.致癌组蛋白 H3K27M 抑制人多梳抑制复合物 2 的结构基础。
Nat Commun. 2016 Apr 28;7:11316. doi: 10.1038/ncomms11316.
9
Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma.PRC2 抑制的多种模式在 H3K27M 型小儿脑胶质瘤中引发全基因组染色质改变。
Sci Adv. 2018 Oct 31;4(10):eaau5935. doi: 10.1126/sciadv.aau5935. eCollection 2018 Oct.
10
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism.PFA 室管膜瘤相关蛋白 EZHIP 通过类似于 H3 K27M 的机制抑制 PRC2 活性。
Nat Commun. 2019 May 13;10(1):2146. doi: 10.1038/s41467-019-09981-6.

引用本文的文献

1
Role of Repressive Histone Lysine Demethylases and Methylases in Susceptibility to Depression Using a Novel Progressive Social Defeat Stress Mouse Model.使用新型渐进性社会挫败应激小鼠模型研究组蛋白赖氨酸去甲基化酶和甲基化酶在抑郁症易感性中的作用
Cell Mol Neurobiol. 2025 Aug 11;45(1):78. doi: 10.1007/s10571-025-01597-3.
2
Aberrant EZHIP expression drives tumorigenesis in osteosarcoma.异常的EZHIP表达驱动骨肉瘤的肿瘤发生。
Nat Commun. 2025 Jul 22;16(1):6752. doi: 10.1038/s41467-025-61558-8.
3
What Epigenetics Teaches Us About Neuron-Glioma Interactions.

本文引用的文献

1
Capturing the Onset of PRC2-Mediated Repressive Domain Formation.捕获 PRC2 介导的抑制性结构域形成的起始。
Mol Cell. 2018 Jun 21;70(6):1149-1162.e5. doi: 10.1016/j.molcel.2018.05.023.
2
H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers.H3.3K27M 突变蛋白通过将 PRC2 复合物隔离到启动子增强子上来重新编程表观基因组。
Elife. 2018 Jun 22;7:e36696. doi: 10.7554/eLife.36696.
3
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.单细胞 RNA 测序解析 H3K27M 型神经胶质瘤中的发育和致癌程序。
表观遗传学让我们了解到的神经元与神经胶质瘤的相互作用
Bioessays. 2025 Sep;47(9):e70043. doi: 10.1002/bies.70043. Epub 2025 Jul 20.
4
Immuno-oncological interactions between meningeal lymphatics and glioblastoma: from mechanisms to therapies.脑膜淋巴管与胶质母细胞瘤之间的免疫肿瘤学相互作用:从机制到治疗
Theranostics. 2025 Jun 9;15(14):6983-7000. doi: 10.7150/thno.111972. eCollection 2025.
5
Molecular Biomarkers of Glioma.神经胶质瘤的分子生物标志物
Biomedicines. 2025 May 26;13(6):1298. doi: 10.3390/biomedicines13061298.
6
Aberrant histone modifications in pediatric brain tumors.小儿脑肿瘤中的异常组蛋白修饰
Front Oncol. 2025 Jun 10;15:1587157. doi: 10.3389/fonc.2025.1587157. eCollection 2025.
7
Investigating oncoprotein-mediated chromatin dysregulation in uncovers novel modifiers of the developmental impact of H3 K27M and EZHIP.研究癌蛋白介导的染色质失调揭示了H3 K27M和EZHIP发育影响的新型调节因子。 (原英文文本似乎不完整,“in”后面缺少具体内容)
bioRxiv. 2025 May 27:2025.05.26.656136. doi: 10.1101/2025.05.26.656136.
8
A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.一种含有CBX4的特定形式的cPRC1被用于介导弥漫性中线胶质瘤中的致癌基因抑制。
Mol Cell. 2025 Jun 5;85(11):2110-2127.e7. doi: 10.1016/j.molcel.2025.04.026. Epub 2025 May 21.
9
CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines.CPI203是一种BET抑制剂,可在多种胶质母细胞瘤细胞系中下调一组一致的DNA合成基因。
PLoS One. 2025 May 16;20(5):e0306846. doi: 10.1371/journal.pone.0306846. eCollection 2025.
10
Tumors and their microenvironments: Learning from pediatric brain pathologies.肿瘤及其微环境:从儿童脑部病理学中学习。
Biochim Biophys Acta Rev Cancer. 2025 Jul;1880(3):189328. doi: 10.1016/j.bbcan.2025.189328. Epub 2025 Apr 18.
Science. 2018 Apr 20;360(6386):331-335. doi: 10.1126/science.aao4750.
4
Accurate H3K27 methylation can be established de novo by SUZ12-directed PRC2.准确的 H3K27 甲基化可以由 SUZ12 定向的 PRC2 从头建立。
Nat Struct Mol Biol. 2018 Mar;25(3):225-232. doi: 10.1038/s41594-018-0036-6. Epub 2018 Feb 26.
5
H3.3 Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas.H3.3在小鼠胚胎神经祖细胞中与Trp53缺失和PDGFRA扩增协同作用,诱导侵袭性高级别胶质瘤。
Cancer Cell. 2017 Nov 13;32(5):684-700.e9. doi: 10.1016/j.ccell.2017.09.014. Epub 2017 Oct 26.
6
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.1000例儿童高级别和弥漫性脑桥内胶质瘤的综合分子荟萃分析
Cancer Cell. 2017 Oct 9;32(4):520-537.e5. doi: 10.1016/j.ccell.2017.08.017. Epub 2017 Sep 28.
7
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.EZH2 是 H3K27M 突变型小儿脑胶质瘤的潜在治疗靶点。
Nat Med. 2017 Apr;23(4):483-492. doi: 10.1038/nm.4293. Epub 2017 Feb 27.
8
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.弥漫性脑桥内在型胶质瘤中多梳蛋白和BET溴结构域蛋白的治疗靶点
Nat Med. 2017 Apr;23(4):493-500. doi: 10.1038/nm.4296. Epub 2017 Feb 27.
9
Identification and Quantification of Histone PTMs Using High-Resolution Mass Spectrometry.使用高分辨率质谱法鉴定和定量组蛋白的翻译后修饰
Methods Enzymol. 2016;574:3-29. doi: 10.1016/bs.mie.2015.12.007. Epub 2016 Feb 1.
10
ChAsE: chromatin analysis and exploration tool.ChAsE:染色质分析与探索工具。
Bioinformatics. 2016 Nov 1;32(21):3324-3326. doi: 10.1093/bioinformatics/btw382. Epub 2016 Jul 4.